1-4 of 4
Bjorn W. Hackanson, MD
Close
Sort by
Journal Articles

Synergistic Reactivation Of Cancer/Testis Antigens By Combination Treatment With Decitabine and Histone Deacetylase Inhibitors (Valproate, Panobinostat) In Myeloid Leukemia Cells

Nadja Blagitko-Dorfs, Ph.D., Tobias Bauer, M.Sc., Maren Prinz, Wolfram Brugger, MD, Gesine Bug, MD, PhD, Katharina Goetze, MD, Michael Heuser, MD, Sabine Kayser, MD, Hans Walter Lindemann, MD, Helmut R. Salih, MD, Björn W. Hackanson, MD, Michael Lübbert, MD
Journal: Blood
Blood (2013) 122 (21): 3763.
https://doi.org/10.1182/blood.V122.21.3763.3763
Published: 2013
Journal Articles

Epigenetic Down-Regulation Of AML2 Expression By EZH2 Contributes To NF-E2 Overexpression In Myeloproliferative Neoplasms

Wei Wang, PhD, Bjorn W. Hackanson, MD, Heike L. Pahl, PhD
Journal: Blood
Blood (2013) 122 (21): 1605.
https://doi.org/10.1182/blood.V122.21.1605.1605
Published: 2013
Journal Articles

Selective HDAC6 Inhibition and Antileukemic Activity of the Novel HDAC Inhibitor ST80 in Myeloid Leukemia Cell Lines.

Bjorn W. Hackanson, MD, Leander Rimmele, Manfred Jung, PhD, Michael Lübbert, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4808.
https://doi.org/10.1182/blood.V114.22.4808.4808
Published: 2009
Journal Articles

Long-Term Follow-up of Patients with Chronic Myeloid Leukemia Having Received Autologous Stem Cell Transplantation.

Bjorn W. Hackanson, MD, Cornelius F Waller
Journal: Blood
Blood (2009) 114 (22): 4268.
https://doi.org/10.1182/blood.V114.22.4268.4268
Published: 2009